Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Genetic markers: progress and potential for cardiovascular disease.

Gibbons GH, Liew CC, Goodarzi MO, Rotter JI, Hsueh WA, Siragy HM, Pratt R, Dzau VJ.

Circulation. 2004 Jun 29;109(25 Suppl 1):IV47-58. Review. No abstract available.

2.

Genetics, genomics, proteomics: what is a cardiologist to do?

Califf RM.

Am Heart J. 2000 Oct;140(4):S48-50. Review. No abstract available.

PMID:
11011324
3.

Biomarkers of cardiovascular disease: molecular basis and practical considerations.

Vasan RS.

Circulation. 2006 May 16;113(19):2335-62. Review. No abstract available.

4.

Genetic and molecular markers for vascular disease. Overview.

Ballantyne CM.

J Cardiovasc Risk. 1997 Oct-Dec;4(5-6):321-3. Review. No abstract available.

PMID:
9865661
5.

Genomics of cardiovascular disease.

Manace LC, Godiwala TN, Babyatsky MW.

Mt Sinai J Med. 2009 Dec;76(6):613-23. doi: 10.1002/msj.20151. Review.

PMID:
20014425
6.

Molecular and genetic approaches to the study of cardiovascular disease.

Hallman DM, Ellsworth DL, Boerwinkle E.

J Cardiovasc Risk. 1997 Oct-Dec;4(5-6):325-31. Review. No abstract available.

PMID:
9865662
7.

[Genetic factors and the risk of cardiovascular diseases].

Teren A, Gavorník P.

Vnitr Lek. 2007 Jun;53(6):678-93. Review. Slovak.

PMID:
17702128
8.

Molecular signatures of cardiovascular disease risk: potential for test development and clinical application.

Schunkert H, König IR, Erdmann J.

Mol Diagn Ther. 2008;12(5):281-7. Review.

PMID:
18803426
9.

Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.

Zaiou M, Benachour H, Marteau JB, Visvikis-Siest S, Siest G.

Curr Pharm Des. 2009;15(27):3193-206. Review.

PMID:
19754391
10.

Genomics of cardiovascular disease.

O'Donnell CJ, Nabel EG.

N Engl J Med. 2011 Dec 1;365(22):2098-109. doi: 10.1056/NEJMra1105239. Review. No abstract available.

11.

New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.

Podgoreanu MV, Schwinn DA.

J Am Coll Cardiol. 2005 Dec 6;46(11):1965-77. Epub 2005 Nov 9. Review.

12.

Genomics and the circulation.

Podgoreanu MV, Schwinn DA.

Br J Anaesth. 2004 Jul;93(1):140-8. Epub 2004 May 14. Review. No abstract available.

PMID:
15145823
13.

Genomics and proteomics methodologies for vulnerable populations research.

Kasper CE.

Annu Rev Nurs Res. 2007;25:191-217. Review.

PMID:
17958293
14.

Prospects for personalized cardiovascular medicine: the impact of genomics.

Ginsburg GS, Donahue MP, Newby LK.

J Am Coll Cardiol. 2005 Nov 1;46(9):1615-27. Epub 2005 Oct 10. Review.

15.

[Cardiovascular diseases: present and future based on molecular biology].

Oseguera Moguel J.

Rev Invest Clin. 2003 Mar-Apr;55(2):155-60. Review. Spanish. No abstract available.

PMID:
12827919
16.

Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.

López-Pedrera C, Barbarroja N, Aguirre MA, Torres LA, Velasco F, Cuadrado MJ.

Lupus. 2008 Oct;17(10):904-15. doi: 10.1177/0961203308095285. Review.

PMID:
18827055
17.

Genetic analysis for common complex disease.

Hauser ER, Pericak-Vance MA.

Am Heart J. 2000 Oct;140(4):S36-44. Review. No abstract available.

PMID:
11011322
18.

Genomics and the cardiac surgeon.

Bullard MK, Swift M, Harken A.

J Card Surg. 2007 Jan-Feb;22(1):83-6. Review.

PMID:
17239225
19.

Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease.

Low YL, Tai ES.

Mutat Res. 2007 Sep 1;622(1-2):7-13. Epub 2007 May 5. Review.

PMID:
17555770
20.

Exploring predisposition and treatment response--the promise of genomics.

Pan S, Knowles JW.

Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):56-63. doi: 10.1016/j.pcad.2012.04.006. Review.

Supplemental Content

Support Center